Qrons

qrons
Founded in 2016, Qrons is a publicly traded, preclinical biotechnology company, developing advanced cell-based solutions to combat neurological injuries. While we are laser-focused on traumatic brain injury (TBI), our technology could potentially treat a wide range of neurodegenerative diseases.

Profile Description

Our TBI treatment integrates proprietary, engineered mesenchymal stem cells (MSCs), 3D printable scaffolding, smart materials and a novel delivery system.

We believe this combination will reduce neuronal loss and functional impairment and possibly regenerate brain tissue and function for TBI patients.

We are developing 3D printable smart material scaffolds, innovative mesenchymal stem cell lines and a novel delivery system to repair and regenerate neuronal damage.

We take a multidisciplinary approach, developing solutions that match the complexity of the conditions we seek to treat. Our unique approach will move our research forward.

Leave a Comment

Time limit is exhausted. Please reload the CAPTCHA.